AzTrials
AzTrials

Fluid ResponsivenessHERONCT07840040

Hemodynamic Evaluation and Fluid Response Observation Through Respiratory Maneuvers

A study testing Respiratory Maneuvers and Fluid Responsiveness Assessment Protocol in people with Fluid Responsiveness and Hemodynamics, run by University Hospital Pilsen at 1 site in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates whether respiratory maneuvers can induce measurable hemodynamic changes and whether these changes may be used to assess fluid responsiveness in healthy volunteers. Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Fluid Responsiveness, Hemodynamics
What is being tested?
Respiratory Maneuvers and Fluid Responsiveness Assessment Protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteCzechia
Study dates
22 Oct 2024to 8 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy volunteers able to understand and perform the study procedures

Who cannot join

  • Age <18 years
  • History of cardiac arrhythmia, coronary artery disease, or valvular heart disease
  • Bronchial asthma or other respiratory disease associated with reduced vital capacity
  • History of increased intraocular pressure, including glaucoma, retinopathy, or intraocular implants
  • Inability to cooperate with the study procedures

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • University Hospital Pilsen

    Pilsen, Czech Republic, 323 00

Other trials in Czechia

About this study

This study evaluates whether respiratory maneuvers can induce measurable hemodynamic changes and whether these changes may be used to assess fluid responsiveness in healthy volunteers. Hemodynamic parameters are continuously monitored non-invasively during four respiratory maneuvers, passive leg raising, and a fluid challenge. The hemodynamic responses to individual respiratory maneuvers are compared with the response to fluid administration.

Read the detailed description

Fluid responsiveness is commonly assessed using dynamic tests that transiently modify cardiac preload. In spontaneously breathing patients, however, assessment of fluid responsiveness remains challenging because many established dynamic indices rely on controlled mechanical ventilation. This proof-of-concept physiological study investigates whether respiratory maneuvers performed during spontaneous breathing induce measurable hemodynamic changes that could potentially be used for the assessment of fluid responsiveness. Healthy volunteers undergo four respiratory maneuvers: maximal inspiration followed by breath-hold, maximal expiration followed by breath-hold, Valsalva maneuver, and Müller maneuver. Hemodynamic variables are continuously monitored non-invasively. The hemodynamic responses to the respiratory maneuvers are evaluated in relation to passive leg raising and a subsequent fluid challenge.

Being tested
Respiratory Maneuvers and Fluid Responsiveness Assessment Protocol
Keywords
fluid responsiveness, non-invasive hemodynamic monitoring, respiratory maneuvers, stroke volume, spontaneous breathing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Respiratory Maneuvers and Fluid Responsiveness Assessment ProtocolProcedure or surgery

    Participants perform four respiratory maneuvers: maximal inspiration followed by breath-hold (M1), maximal expiration followed by breath-hold (M2), Valsalva maneuver (M3), and Müller maneuver (M4). Each respiratory maneuver lasts 20 seconds. The respiratory maneuvers are followed by passive leg raising and a fluid challenge consisting of 500 mL of balanced crystalloid administered intravenously over 10 minutes. Hemodynamic variables are continuously monitored non-invasively throughout the protocol.

Study groups in NCT07840040
Study groupRoleWhat they receive
Respiratory Maneuvers and Fluid Responsiveness AssessmentExperimentalHealthy volunteers undergo a hemodynamic assessment protocol consisting of four respiratory maneuvers, passive leg raising, and a fluid challenge, with continuous non-invasive hemodynamic monitoring.
Receives: Procedure: Respiratory Maneuvers and Fluid Responsiveness Assessment Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in heart rate during respiratory manoeuvres

    Change in heart rate (HR), measured in beats per minute (bpm), during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  2. Change in systolic arterial pressure during respiratory manoeuvres

    Change in systolic arterial pressure (SAP), measured in mmHg, during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  3. Change in mean arterial pressure during respiratory maneuvers

    Change in mean arterial pressure (MAP), measured in mmHg, during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  4. Change in pulse pressure variation during respiratory manoeuvres

    Change in pulse pressure variation (PPV), measured as a percentage (%), during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  5. Change in cardiac index during respiratory manoeuvres

    Change in cardiac index (CI), measured in L/min/m², during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  6. Change in stroke volume index during respiratory maneuvers

    Change in stroke volume index (SVI), measured in mL/m², during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  7. Change in systemic vascular resistance index during respiratory maneuvers

    Change in systemic vascular resistance index (SVRI), measured in dyn·s·cm-⁵·m², during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

  8. Change in stroke volume variation during respiratory manoeuvres

    Change in stroke volume variation (SVV), measured as a percentage (%), during each of four respiratory maneuvers using continuous non-invasive hemodynamic monitoring.

    Measured: During each 20-second respiratory maneuver, within a single study visit.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start22 Oct 2024
  3. Primary completion8 Dec 2025
  4. Study completion8 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07840040
Sponsor's protocol ID
HERO
Acronym
HERO
Status last verified
Sep 2026
First submitted
7 Sep 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Respiratory Maneuvers and Fluid Responsiveness Assessment Protocol in people with Fluid Responsiveness and Hemodynamics, run by University Hospital Pilsen at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in heart rate during respiratory manoeuvres (time frame: During each 20-second respiratory maneuver, within a single study visit.). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in